Mechanism of cardioprotective effect of orotic acid

Cardiovascular Drugs and Therapy

Volumn 12, Issue SUPPL. 2, 1998, Pages 159-170

  Rosenfeldt, Franklin L ^a   Richards, Stephen M ^a,c   Lin, Zaw ^a   Pepe, Salvatore ^a   Conyers, Robert A J ^b  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Infarction; Myocardial ischemia; Orotic acid; Purines

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE TRIPHOSPHATE; CYTIDINE; OROTIC ACID; PYRIMIDINE; RNA; URIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; ENERGY RESOURCE; GLYCOLYSIS; HEART; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART PROTECTION; INTRAGASTRIC DRUG ADMINISTRATION; LIVER; MALE; METABOLITE; NONHUMAN; PLASMA; PRIORITY JOURNAL; RAT; RNA SYNTHESIS; STRESS;

ADENINE NUCLEOTIDES; ANIMALS; ANOXIA; HEART; LIVER; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; OROTIC ACID; OXYGEN CONSUMPTION; PURINES; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; URIDINE;

EID: 0031695868     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1007700716866     Document Type: Article

References (45)

1. Kolos G, Williams JF, Hickie JB. Biochemical studies in myocardial hypertrophy and metabolic support of the acutely stressed myocardium. Adv Cardiol 1974;12:106-115.
2. Munsch C, Williams JF, Rosenfeldt FL. The impaired tolerance of the recently infarcted rat heart to cardioplegic arrest: The protective effect of orotic acid. J Mol Cell Cardiol 1989;21:751-754.
3. Bailey LE. Orotic acid prevents changes in cardiac sarcolemmal glycoproteins and contractility associated with muscular dystrophy in hamsters. Experentia 1980;36:6-7.
4. Yeh T Jr, Rebeyka IM, Jakoi ER, Johnson DE, Dignan RJ, Dyke CM, Wechler AS. Orotic acid improves left ventricular recovery four days after heterotopic transplantation. Ann Thorac Surg 1994;58:409-415.
5. Newman MAJ, Chen X-Z, Rabinov M, Williams JF, Rosen feldt FL. Sensitivity of the recently infarcted heart to cardioplegic arrest. J Thorac Cardiovasc Surg 1989;97: 593-604.
6. Munsch CM, Rosenfeldt FL, O'Halloran K, Langley LH, Conyers RAJ, Williams JF. The effect of orotic acid on the response of the recently infarcted rat heart to hypothermie cardioplegia. Eur J Cardiothorac Surg 1991;5:82-93.
7. Meerson FZ. The myocardium in hyperfunction, hypertrophy and heart failure. Circ Res 1969;24,25(Suppl.2): II146-II155.
8. Donahoe JA, Rosenfeldt FL, Munsch CM, Williams JF. The effect of orotic acid treatment on the energy and carbohydrate metabolism of the hypertrophying rat heart. Int J Biochem 1993;25:163-182.
9. Windmueller HG, Levy RI. Total inhibition of hepatic betalipoprotein production in the rat by orotic acid. J Biol Chem 1967;242:2246-2254.
10. Gasser T, Moyer JD, Handschumacher RE. Novel singlepass exchange of circulating uridine in rat liver. Science 1981;213:777-778.
11. Pels Rijcken WR, Hooghwinkel GJM, Ferwerda W Pyrimidine metabolism and sugar nucleotide synthesis in rat liver. Biochem J 1990;266:777-783.
12. Monks A, Ayers O, Cysyk RL. Effect of 5-benzylacyclouridine, a potent inhibitor of uridine phosphorylase, on the metabolism of circulating uridine by the isolated rat liver. Biochem Pharmacol 1983;32:2003-2009.
13. Holstege A, Manglitz D, Gerok W. Depletion of blood plasma cytidine due to increased hepatocellular salvage in D-galactosamine-treated rats. Eur J Biochem 1984;141:339-344.
14. Lortet S, Aussedat J, Rossi A. Pyrimidine nucleotide synthesis from exogenous cytidine in the isolated rat heart. Basic Res Cardiol 1986;81:303-310.
15. Lea MA, Luke A, Oliphant V. Selective modulation of nucleotide concentrations in rat liver and hepatomas by highorotate or arginine-deficient diets and by carbamoylating agents. Biochim Biophys Acta 1988;964:121-128.
16. Monks A, Chisena CA, Cysyk RL. Influence of ammonium ions on hepatic de novo pyrimidine biosynthesis. Arch Biochem Biophys 1985;236:1-10.
17. Aussedat J, Ray A, Rossi A. Uridine incorporation in normal and ischemic perfused rat heart. Mol Physiol 1984; 6:247-256.
18. Taegtmeyer H, Hems R, Krebs HA. Utilisation of energy providing substrates in the isolated working rat heart, Biochem J 1980;186:701-711.
19. Strobeck JE, Sonnenblick EH. Myocardial contractile properties and ventricular performance. In: Fozzard HA, Haber E, Jennings RB, eds. Heart and Cardiovascular System. New York: Raven Press. 31-49.
20. Kannengiesser GJ, Opie LH, Van der Werf TJ. Impaired cardiac work and oxygen uptake after reperfusion of regionally ischemic myocardium. J Mol Cell Cardiol 1979;11:197-207.
21. Richards SM, Conyers RAJ, Fisher JL, Rosenfeldt FL. Cardioprotection by orotic acid: Metabolism and mechanism of action. J Mol Cell Cardiol 1997;29:3239-3250.
22. Schaper W, Frenzel H, Hort W. Experimental coronary artery occlusion. I. Measurement of infarct size. Basic Res Cardiol 1979;74:46-53.
23. Lin Z, Richards SM, Pepe S, Rosenfeldt FL. Uridine preserves ATP during hypoxic perfusion of the rat heart. Asia Pacific Heart J 1997;6(3):190-196.
24. Snedecor GW, Cochrane WG. Statistical Methods, 7th ed. Ames, IA: Iowa State University Press, 1980:401.
25. Olivares J, Ray A, Aussedat J, Verdys M, Rossi A. Increased pyrimidine nucleotide synthesis in isoproterenol-induced cardiac hypertrophy in rats. Biochem Biophys Res Commun 1980;95:367-376.
26. Rossi A, Aussedat J, Olivares J, Ray A, Verdys M. Pyrimidine nucleotide metabolism in cardiac hypertrophy. Eur Heart J 1984;5(Suppl. F):155-162.
27. Keppler D, Holstege A. Pyrimidine nucleotide metabolism and its compartmentation. In: Sies H, ed. Metabolic Compartmentation. London: Academic Press, 1982:147-203.
28. Ashford AJ, Pain VM. Effect of diabetes on the rates of synthesis and degradation of ribosomes in rat muscle and liver in vivo. J Biol Chem 1986;261:4059-4065.
29. Durshlag RP, Robinson JL. Orotic acid-induced metabolic changes in the rat. J Nutr 1980;110:816-821.
30. Fausto N. The conversion of orotic acid into uridine 5'-monophosphate by isolated perfused normal and regenerating rat livers. Biochem J 1972;129:811-820.
31. Bontemps F, Vincent MF, van den Berghe G. Mechanisms of elevation of adenosine concentrations in anoxic hepatocytes. Biochem J 1993;290:671-677.
32. Moyer JD, Oliver JT, Handschumacher RE. Salvage of circulating pyrimidine nucleosides in the rat. Cancer Res 1981;41:3010-3017.
33. Aussedat J. Effect of uridine supply on glycogen resynthesis after ischemia in the isolated perfused rat heart. Cardiovasc Res 1983;17:145-151.
34. Kypson J, Hait G, Mathew R. Effects of uridine on the performance and the metabolism of oxygenated and hypoxic rabbit hearts. J Mol Cell Cardiol 1978;10:545-565.
35. Braasch W, Gudbjarnason S, Puri P, et al. Early changes in energy metabolism in the myocardium following acute coronary artery occlusion in anaesthetised dogs. Circ Res 1968;23:429-38.
36. +-stimulated ATPase activities in ischemie and non-ischemic areas of the myocardium with acute experimental coronary occlusion. J Mol Cell Cardiol 1974;6:567-574.
37. Beyersdorf F, Acar C, Buckberg G. Studies on prolonged acute regional ischemia. III. Early natural history of simulated single and multi vessel disease with emphasis on remote myocardium. J Thorac Cardiovasc Surg 1989;98: 368-380.
38. Gudbjarnason S, Puri P, Mathes P. Biochemical changes in non-infarcted heart muscle following myocardial infarction. J Mol Cell Cardiol 1971;2:253-276.
39. Zimmer H-G, Martius PA, Marschner G. Myocardial infarction in rats: Effects of metabolic and pharmacologic interventions. Basic Res Cardiol 1989;84:332-343.
40. Ingwall JS, Atkinson DE, Clarke K, Fetters JK. Energetic correlates of cardiac failure: Changes in the creatine kinase system in the failing myocardium. Eur Heart J 1990; 11 (Suppl. B):108-115.
41. Allard MF, Flint JDA, English JC, Henning SL, Salamanca MC, Kamimura CT, English DR. Calcium overload during reperfusion is accelerated in isolated hypertrophied rat hearts. J Mol Cell Cardiol 1994;26:1551-1563.
42. Attarian DE, Jones RN, Currie WD,et al. Characteristics of chronic left ventricular hypertrophy induced by subcoronary valvular aortic stenosis. II. Response to ischemia. J Thorac Cardiovasc Surg 1981;81:389-395.
43. Galinanes M, Smolenski RT, Hearse DJ. Brain death-induced cardiac contractile dysfunction and long-term cardiac preservation. Rat heart studies of the effects of hypophysectomy. Circulation 1993;88:270-280.
44. Jennings RB, Steenbergen C Jr. Nucleotide metabolism and cellular damage in myocardial ischemia. Ann Rev Physiol 1985;47:727-749.
45. von Kugelgen I, Schoffel E, Starke K. Inhibition by nucleotides acting at presynaptic p2-receptors of sympathetic neuro-effector transmission in the mouse isolated vas deferens. Naunyn Schmiedebergs Arch Pharmacol 1989;340: 522-532.